Data / Form D filings / QSAM Biosciences, Inc.
QSAM Biosciences, Inc.: Form D filings
QSAM Biosciences, Inc., a biotechnology company in Austin, TX, filed 12 Form D notices with the SEC between 2009 and 2022. The latest, on October 6, 2022, reports $925,000 sold of a $3.5 million offering to 3 investors.
Find out what QSAM Biosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9442 CAPITAL OF TEXAS HWY N, PLAZA 1 SUITE 500, Austin, TX, 78759
- Phone
- (512) 343-4558
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1310527
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6, 2022 | New notice | $3,500,000 | $925,000 | $2,575,000 | 3 | Sep 30, 2022 | sec.gov |
| Nov 15, 2021 | New notice | $1,000,000 | $555,000 | $445,000 | 6 | Oct 31, 2021 | sec.gov |
| Feb 5, 2021 | New notice | $2,500,000 | $2,500,000 | $0 | 29 | Jan 27, 2021 | sec.gov |
| Apr 10, 2017 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 20 | Mar 31, 2017 | sec.gov |
| Dec 11, 2015 | New notice | $1,500,000 | $500,000 | $1,000,000 | 1 | Nov 12, 2015 | sec.gov |
| Dec 7, 2015 | New notice | $7,200,000 | $7,200,000 | $0 | 83 | Nov 12, 2015 | sec.gov |
| Jul 3, 2014 | New notice | $435,750 | $435,750 | $0 | 1 | Jul 2, 2014 | sec.gov |
| Jul 3, 2013 | New notice | $2,000,000 | $25,000 | $1,975,000 | 1 | Jun 21, 2013 | sec.gov |
| May 22, 2013 | New notice | $200,000 | $200,000 | $0 | 1 | May 14, 2013 | sec.gov |
| Dec 22, 2009 | New notice | $4,000,000 | $495,000 | $3,505,000 | 8 | Aug 25, 2009 | sec.gov |
| Jul 9, 2009 | Amendment | $5,000,000 | $891,789 | $4,108,211 | 29 | Apr 8, 2009 | sec.gov |
| Apr 22, 2009 | New notice | $5,000,000 | $537,309 | $4,462,691 | 21 | Apr 8, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adriann Sax | Director | |
| C. Richard Piazza | Executive Officer, Director | |
| Adam King | Executive Officer | |
| Christopher M Nelson | Executive Officer | |
| Douglas Baum | Executive Officer, Director | |
| Charles J. Link Jr. | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Oct 3, 2022 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what QSAM Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.